Kilpatrick Townsend’s Silicon Valley-based start-up team advised the founders of Editas Medicine in the biotech start-up’s $43 million Series A Financing. In a trend setting transaction, venture firms Polaris Partners, Third Rock Ventures, Flagship Ventures and the Partners Innovation Fund invited five of the most prominent research scientists in the field of genomics from MIT, Harvard, the Howard Hughes Medical Institute and the University of California in Berkeley to form a company which they would fund. The money invested will fund the collaborative research and development by this world-class team of scientists as they seek to revolutionize the treatment of genetic disorders by developing a simple, precise and inexpensive method of ‘editing out’ abnormalities in genes in human cells.

Experience Center

Match our Experience to Your Needs

View All Case Studies

Experience Highlights

Sherman Act conspiracy and monopoly claims against obstetrical staff of a major regional hospital
Represented the obstetrical staff of a major regional hospital in resisting Sherman Act conspiracy and monopoly claims made by a group of licensed more
Employee benefits advice for one of the nation's largest providers of telephone and broadband services
Advised one of the nation's largest providers of telephone and broadband services with respect to compensation and employee benefit plan issues in a more
Banking and financial services for servicers and lenders
Represents servicers and lenders in post-origination loan modifications, loan assumptions, and loan defeasances. more
Glow Industries Inc. v. Lopez and Coty Inc. et al.
Defeated motion for a preliminary injunction in trademark infringement action against Jennifer Lopez and Coty Inc. based on alleged likelihood of more